Literature DB >> 18440578

Differential mechanisms of complement-mediated neutralization of the closely related paramyxoviruses simian virus 5 and mumps virus.

John B Johnson1, Gerald A Capraro, Griffith D Parks.   

Abstract

The complement system is an important component of the innate immune response to virus infection. The role of human complement pathways in the in vitro neutralization of three closely related paramyxoviruses, Simian Virus 5 (SV5), Mumps virus (MuV) and Human Parainfluenza virus type 2 (HPIV2) was investigated. Sera from ten donors showed high levels of neutralization against HPIV2 that was largely complement-independent, whereas nine of ten donor sera were found to neutralize SV5 and MuV only in the presence of active complement pathways. SV5 and MuV neutralization proceeded through the alternative pathway of the complement cascade. Electron microscopy studies and biochemical analyses showed that treatment of purified SV5 with human serum resulted in C3 deposition on virions and the formation of massive aggregates, but there was relatively little evidence of virion lysis. Treatment of MuV with human serum also resulted in C3 deposition on virions, however in contrast to SV5, MuV particles were lysed by serum complement and there was relatively little aggregation. Assays using serum depleted of complement factors showed that SV5 and MuV neutralization in vitro was absolutely dependent on complement factor C3, but was not dependent on downstream complement factors C5 or C8. Our results indicate that even though antibodies exist that recognize both SV5 and MuV, they are mostly non-neutralizing and viral inactivation in vitro occurs through the alternative pathway of complement. The implications of our work for development of paramyxovirus vectors and vaccines are discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18440578      PMCID: PMC2398685          DOI: 10.1016/j.virol.2008.03.022

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  55 in total

1.  The paramyxovirus SV5 V protein binds two atoms of zinc and is a structural component of virions.

Authors:  R G Paterson; G P Leser; M A Shaughnessy; R A Lamb
Journal:  Virology       Date:  1995-04-01       Impact factor: 3.616

Review 2.  Toward novel vaccines and therapies based on negative-strand RNA viruses.

Authors:  V von Messling; R Cattaneo
Journal:  Curr Top Microbiol Immunol       Date:  2004       Impact factor: 4.291

3.  Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps virus genotype.

Authors:  J Nöjd; T Tecle; A Samuelsson; C Orvell
Journal:  Vaccine       Date:  2001-02-08       Impact factor: 3.641

4.  Cold activation of serum complement in patients with chronic hepatitis C: study on activating pathway and involvement of IgG.

Authors:  Y Ishii; H Shimomura; M Itoh; M Miyake; F Ikeda; J Miyaike; S Fujioka; Y Iwasaki; H Tsuji; T Tsuji
Journal:  Acta Med Okayama       Date:  2001-08       Impact factor: 0.892

5.  Controlled cell killing by a recombinant nonsegmented negative-strand RNA virus.

Authors:  Griffith D Parks; Virginia A Young; Constantinos Koumenis; Elizabeth K Wansley; Jennifer L Layer; Kelly M Cooke
Journal:  Virology       Date:  2002-02-01       Impact factor: 3.616

6.  High avidity cytotoxic T lymphocytes to a foreign antigen are efficiently activated following immunization with a recombinant paramyxovirus, simian virus 5.

Authors:  Griffith D Parks; Martha A Alexander-Miller
Journal:  J Gen Virol       Date:  2002-05       Impact factor: 3.891

7.  Novel mechanism of antibody-independent complement neutralization of herpes simplex virus type 1.

Authors:  H M Friedman; L Wang; M K Pangburn; J D Lambris; J Lubinski
Journal:  J Immunol       Date:  2000-10-15       Impact factor: 5.422

8.  Naturally occurring substitutions in the P/V gene convert the noncytopathic paramyxovirus simian virus 5 into a virus that induces alpha/beta interferon synthesis and cell death.

Authors:  Elizabeth K Wansley; Griffith D Parks
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Cell surface activation of the alternative complement pathway by the fusion protein of measles virus.

Authors:  Patricia Devaux; Dale Christiansen; Sébastien Plumet; Denis Gerlier
Journal:  J Gen Virol       Date:  2004-06       Impact factor: 3.891

Review 10.  The relevance of complement to virus biology.

Authors:  Clare E Blue; O Brad Spiller; David J Blackbourn
Journal:  Virology       Date:  2004-02-20       Impact factor: 3.616

View more
  33 in total

1.  Comparison of differing cytopathic effects in human airway epithelium of parainfluenza virus 5 (W3A), parainfluenza virus type 3, and respiratory syncytial virus.

Authors:  Liqun Zhang; Peter L Collins; Robert A Lamb; Raymond J Pickles
Journal:  Virology       Date:  2011-10-08       Impact factor: 3.616

Review 2.  Paramyxovirus activation and inhibition of innate immune responses.

Authors:  Griffith D Parks; Martha A Alexander-Miller
Journal:  J Mol Biol       Date:  2013-09-20       Impact factor: 5.469

3.  Incorporation of host complement regulatory proteins into Newcastle disease virus enhances complement evasion.

Authors:  Moanaro Biswas; John B Johnson; Sandeep R P Kumar; Griffith D Parks; Subbiah Elankumarana; Elankumaran Subbiah
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

4.  Mumps virus inhibits migration of primary human macrophages toward a chemokine gradient through a TNF-alpha dependent mechanism.

Authors:  Caitlin M Briggs; Anne E Mayer; Griffith D Parks
Journal:  Virology       Date:  2012-08-28       Impact factor: 3.616

5.  Interactions of human complement with virus particles containing the Nipah virus glycoproteins.

Authors:  John B Johnson; Hector C Aguilar; Benhur Lee; Griffith D Parks
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

6.  The Bordetella pertussis Bps polysaccharide enhances lung colonization by conferring protection from complement-mediated killing.

Authors:  Tridib Ganguly; John B Johnson; Nancy D Kock; Griffith D Parks; Rajendar Deora
Journal:  Cell Microbiol       Date:  2014-02-13       Impact factor: 3.715

7.  A hyperfusogenic F protein enhances the oncolytic potency of a paramyxovirus simian virus 5 P/V mutant without compromising sensitivity to type I interferon.

Authors:  Maria D Gainey; Mary J Manuse; Griffith D Parks
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

8.  Experimental vaccines against potentially pandemic and highly pathogenic avian influenza viruses.

Authors:  Alaina J Mooney; S Mark Tompkins
Journal:  Future Virol       Date:  2013-01-01       Impact factor: 1.831

9.  The paramyxoviruses simian virus 5 and mumps virus recruit host cell CD46 to evade complement-mediated neutralization.

Authors:  John B Johnson; Ken Grant; Griffith D Parks
Journal:  J Virol       Date:  2009-05-20       Impact factor: 5.103

10.  Functions of Antibodies.

Authors:  Donald N Forthal
Journal:  Microbiol Spectr       Date:  2014-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.